Neural Control of Non-invasive Ventilation in the Preterm
Respiratory Distress Syndrome, Newborn, Infant, Premature
About this trial
This is an interventional treatment trial for Respiratory Distress Syndrome, Newborn focused on measuring diaphragm electrical activity, non invasive ventilation, patient ventilator interaction
Eligibility Criteria
Inclusion Criteria: Part 1: Preterm newborns (>1 week postnatal age, gestational age> 23 weeks, birth weight <1000g), intubated and mechanically ventilated, and breathing spontaneously. Infants should be breathing on a triggered mode of ventilation (SIMV, assist control, or pressure support) with the following ventilator parameters: assist control/pressure support < 20 cm H2O, PEEP4-7 cm H2O, SIMV rate< 30, FIO2<40%/. Part 2:Newborns recovering from respiratory illness and deemed to be ready for elective extubation by their attending physician, intubated and mechanically ventilated, and breathing spontaneously. Exclusion Criteria: Protocols 1 and 2: Pneumothorax, degenerative neuromuscular disease, bleeding disorders, cardiovascular instability (defined as hypotension or need for treatment with volume expansion or inotropes in the previous 24 hours), cyanotic congenital cardiovascular disease, treatment with narcotics, phrenic nerve damage/diaphragm paralysis, esophageal perforation, use of high frequency oscillatory ventilation
Sites / Locations
- Sunnybrook Health Sciences Centre